Evidence map›Paper›PMID 40940618›Full record

ArticleBiotechnology letters2025

Novel TdsD nitroreductase: characterization of kinetics and substrate specificity.

Benjaminas Valiauga, Dovydė Žulpaitė, Abigail V Sharrock, David F Ackerley, Narimantas Čėnas

Abstract read
PubMed Publisher
In one paragraph

Article in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Benjaminas ValiaugaInstitute of Biochemistry of Vilnius University, Saulėtekio 7, 10257, Vilnius, Lithuania.
Dovydė ŽulpaitėInstitute of Biochemistry of Vilnius University, Saulėtekio 7, 10257, Vilnius, Lithuania.
Abigail V SharrockSchool of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington, 6140, New Zealand.
David F AckerleySchool of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington, 6140, New Zealand.
Narimantas ČėnasInstitute of Biochemistry of Vilnius University, Saulėtekio 7, 10257, Vilnius, Lithuania. narimantas.cenas@bchi.vu.lt.ORCID http://orcid.org/0009-0007-4652-794X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reduction of quinones and nitroaromatic compounds catalyzed by Type I nitroreductases is important due to its role in their potential cytotoxic effects and/or biodegradation. The main goal of this work was to investigate the mechanism of catalysis of a TdsD nitroreductase (NR) (TdsD1), a member from an understudied branch of the nitroreductase superfamily, derived from a soil metagenome study. Like the Type I NRs NfsA and NfsB, TdsD1 performed two-electron reduction of quinones and four-electron reduction of nitroaromatic compounds according to a "ping-pong" mechanism with a rate-limiting oxidative half-reaction. TdsD1 was also inhibited by the classical inhibitors of other NRs, dicoumarol and Cibacron blue. Despite sharing only a low degree of homology with the NfsA and NfsB subfamily enzymes, sequence comparisons and computer modelling point to the possibility of an analogous FMN isoalloxazine ring location within the intersubunit space of TdsD1. It also possesses similar specificity for nitroaromatic compounds and quinones, in particular the shared characteristic of being especially active with 2-hydroxy-1,4-naphthoquinone derivatives. It is possible that the similar character of binding of oxidants and other ligands relative to the NfsA and NfsB subfamily enzymes may be related to the conserved Arg27 and Ser53 residues in the active site of TdsD1.

Indexed as

NitroreductasesKineticsModels, MolecularOxidation-ReductionQuinonesSubstrate SpecificityNitroreductasesQuinonesCB1954GDEPTNitroaromatic compoundsNitroreductaseQuinonesTdsD

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.